| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-10 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |